SCHEDULE 13G

Company

Spyre Therapeutics, Inc.

Filed

October 23, 2024

Accession Number

0001683168-24-007319

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →